Effects of CYP2C9 polymorphisms on phenprocoumon anticoagulation status

Clin Pharmacol Ther. 2005 Apr;77(4):335-6; author reply 336. doi: 10.1016/j.clpt.2005.01.012.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / pharmacology*
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Blood Coagulation / drug effects
  • Blood Coagulation / genetics*
  • Cytochrome P-450 CYP2C9
  • Humans
  • Phenprocoumon / pharmacology*
  • Polymorphism, Genetic

Substances

  • Anticoagulants
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases
  • Phenprocoumon